Postdoctoral scientist openings at the interface between nanoelectronics and biology broadly defined are currently available in the following areas: (1) Nanoelectronic Tools for Brain Science and (2) Nanoelectronics-Innervated Synthetic Tissues. A background in neuroscience, nanoelectronics, tissue engineering or related fields, and a strong motivation to push the frontiers of science and technology, are important. Interested individuals are encouraged to contact Professor Lieber to explore these opportunities further.
Since 2017 Acapela deploys DNN-based Text-to-Speech on the market, new exciting techniques will be deployed in 2018! You are a creative and motivated individual with a keen interest in Deep Learning, join us to apply your skills in the field of speech synthesis.
You will be part of a team that designs, develops, tests, and deploys text-to-speech technologies supporting a range of products
and services in a large portfolio of languages.
With other members of the team, you will be able to develop advanced solutions that will help a large number of people in their day-to-day life.
The group has published several instructive books, including the advanced and widely used textbooks Classics in Total Synthesis (K. C. Nicolaou and Erik J. Sorensen, VCH, 1996), Classics in Total Synthesis II (K. C. Nicolaou and Scott A. Snyder, Wiley-VCH, 2003), Molecules That Changed the World (K. C. Nicolaou and T. Montagnon, Wiley-VCH, 2008), and Classics in Total Synthesis III (K. C. Nicolaou and J. S. Chen, Wiley-VCH, 2011). Enjoy the tour of our world.
Synthesis Targets are capable of deploying different special abilities, which unlock upon their first node being scanned. They can use these abilities to impede player attempts at scanning them, whether by dealing damage or enhancing their chances at evading the player. A Synthesis Target can only have one particular ability at a time, and the ability they receive will be random. Certain Synthesis Targets, namely those of the faction, have been known to ignore their special abilities. Some known abilities are listed below:
Synthesis Energy Systems (SES) has developed, demonstrated, and deployed its advanced fluidized bed SES Gasification Technology, which is able to cleanly convert low-grade, low-cost coal, coal wastes, and biomass into multiple high-value end products without the same level of capital investment required for most gasification projects. Based on the fuel flexibility and lower upfront costs, SES’ fluidized bed gasification technology has been breaking barriers to enter markets previously not considered feasible for smaller-scale gasification projects. The products at such facilities include direct reduced iron steel, transportation fuels, chemicals, fertilizers, coal-derived synthetic natural gas, and power generation—the one market segment where it has been most difficult for gasification to succeed economically.
I siti produttivi sono Helsinn Advanced Synthesis SA con sede a Biasca (Svizzera) e Helsinn Birex Pharmaceutical Ltd. con sede a Damastown (Irlanda).Il Gruppo Helsinn ha negli scorsi anni acquisito una società biofarmaceutica americana con sede a Bridgewater, New Jersey, ed ha portato alla nascita di Helsinn Therapeutics (U.S.) Inc.